Craig-Hallum Maintains Buy on Fennec Pharmaceuticals, Lowers Price Target to $17
Craig-Hallum Maintains Buy on Fennec Pharmaceuticals, Lowers Price Target to $17
Craig-Hallum維持對Fennec製藥的買入，將目標股價下調至17美元
Craig-Hallum analyst Chase Knickerbocker maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and lowers the price target from $20 to $17.
Craig-Hallum分析師Chase Knickerbocker維持Fennec Pharmicals（納斯達克股票代碼：FENC）的買入並將目標股價從20美元下調至17美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。